The days of worrying about the diagnosis and treatment of cancer are in the past. Presently, many cancer care centers have come together and developed guidelines on systematic and whole-body treatments for men suffering from metastatic castration-resistant prostate cancer.
Prostate cancer in men is often caused by an abnormality in the male sex hormone, androgen. For cancer to stop growing, further hormone therapy surgeries or drugs are available. But sometimes, due to metastasis, cancer might spread beyond the prostate. Eventually, cancer might get castration-resistant. That is, it might spread despite receiving hormone therapy. In this case, further use of drugs and treatment are required to prevent cancer growth.
Indenza 40mg capsules are one of the few effective capsules that can help patients in this case. It is an anti-cancer medicine prescribed by many doctors. The metastatic castration-resistant prostate cancer grows even when the patients are under medication or treatment, lowering the secreted amount of male sex hormones.
Even though the hormone therapy fails to work, the guidelines provided by numerous cancer centers suggest that men having metastatic castration-resistant prostate cancer should continue the therapy to keep the levels of androgen low in their bodies. Along with the therapy, a few other treatments are used to take care of cancer.
These treatments include:
- Radium-223 for men whose cancer has spread to the bones
- Sipuleucel-T for men having little symptoms
- Docetaxel (Docefrez, Taxotere) and prednisone
- Enzalutamide
Enzalutamide is very effective in treating men who have metastatic castration-resistant prostate cancer. This treatment is prescribed after the disease has progressed during and after Docetaxel therapy.
Indenza medicines produce these Enzalutamide 40mg medicines used in the cancer treatment of prostate glands. The original brand of medicine is Xtandi, which is still produced under Indenza medicines. It falls under the category of anti-androgens, which reduces the secretion of male hormones and blocks male hormones’ effects. So, to stop the progression of metastatic castration-resistant prostate cancer in any further parts of the body, Enzalutamide may come in handy.
